Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CYTOSORBENTS MEDICAL INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2021-04-21 to 2024-08-20
Current total value of award: $1499987.16
Description: DHA SBIR SEQUENTIAL PH II - H2S-0011.  PER SECTION 711 OF THE 2019 NDAA, USAMRAA TRANSFERRED TO DHA 10/1/2022.  TWELVE-MONTH NO-COST EXTENSION.